ub.xmlui.mirage2.page-structure.muninLogoub.xmlui.mirage2.page-structure.openResearchArchiveLogo
    • EnglishEnglish
    • norsknorsk
  • Velg spraakEnglish 
    • EnglishEnglish
    • norsknorsk
  • Administration/UB
View Item 
  •   Home
  • Det helsevitenskapelige fakultet
  • Institutt for farmasi
  • Artikler, rapporter og annet (farmasi)
  • View Item
  •   Home
  • Det helsevitenskapelige fakultet
  • Institutt for farmasi
  • Artikler, rapporter og annet (farmasi)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): A quasi-experimental before-after study

Permanent link
https://hdl.handle.net/10037/20183
DOI
https://doi.org/10.1186/s12902-020-00630-4
Thumbnail
View/Open
article.pdf (492.9Kb)
Published version (PDF)
Date
2020-10-01
Type
Journal article
Tidsskriftartikkel
Peer reviewed

Author
Raknes, Guttorm; Småbrekke, Lars
Abstract
Background - Low dose naltrexone (LDN) is reported to have beneficial effects in several autoimmune diseases. The purpose of this study was to examine whether starting LDN was followed by changes in the dispensing of thyroid hormones to patients with hypothyroidism.

Methods - We performed a quasi-experimental before-after study based on the Norwegian Prescription Database. Study participants were identified by using reimbursement codes for hypothyroidism. Cumulative dispensed Defined Daily Doses and the number of users of triiodothyronine (T3) and levothyroxine (LT4) 1 year before and after the first LDN prescription was compared in three groups based on LDN exposure.

Results - We identified 898 patients that met the inclusion criteria. There was no association between starting LDN and the subsequent dispensing of thyroid hormones. If anything, there was a tendency towards increasing LT4 consumption with increasing LDN exposure.

Conclusion - The results of this study do not support claims of efficacy of LDN in hypothyroidism.

Publisher
BMC
Citation
Raknes, Småbrekke. No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): A quasi-experimental before-after study. BMC Endocrine Disorders. 2020;20(1)
Metadata
Show full item record
Collections
  • Artikler, rapporter og annet (farmasi) [394]
Copyright 2020 The Author(s)

Browse

Browse all of MuninCommunities & CollectionsAuthor listTitlesBy Issue DateBrowse this CollectionAuthor listTitlesBy Issue Date
Login

Statistics

View Usage Statistics
UiT

Munin is powered by DSpace

UiT The Arctic University of Norway
The University Library
uit.no/ub - munin@ub.uit.no

Accessibility statement (Norwegian only)